WHO ICTRP trial
Biomarkers predictive for clinical efficacy of anti-interleukin-5 receptor alpha…
JPRN-UMIN000031905 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000031905 |
|---|---|
| Public title | Biomarkers predictive for clinical efficacy of anti-interleukin-5 receptor alpha monoclonal antibody in patients with asthma |
| Scientific title | Biomarkers predictive for clinical efficacy of anti-interleukin-5 receptor alpha monoclonal antibody in patients with asthma - Biomarkers foranti-interleukin-5 receptor alpha monoclonal antibody |
| Primary sponsor | Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Bronchial asthma |
| Registration date | Mar 26, 2018 |
| Target size | 110 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: